Keywords: Mild stroke, Tissue plasminogen activator, Clot-busting drug, Savings

Treating mild strokes with clot-busting drug could save USA $200 million annually, study shows

Article | 11 February 2011

Treating mild strokes with the clot-busting drug approved for severe stroke could reduce the number of patients left disabled and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in